Most likely a small note was sold off on 10/7...hopefully not a continuation of selling here.
On October 9, 2019, BioVie Inc., a Nevada corporation (the “Company”), entered into an amendment (the “Amendment”) to a Securities Purchase Agreement (the “Purchase Agreement”) dated as of September 24, 2019 with Acuitas Group Holdings, LLC (“Acuitas”) pursuant to which (i) Acuitas purchased a 10% OID Convertible Delayed Draw Debenture (the “Debenture”) due September 24, 2020 in aggregate commitment amount of up to $2.0 million, and (ii) the Company issued 140,625,000 shares of the Company’s Class A Common Stock (the “Common Stock”) and warrants (the “Commitment Warrants”) to purchase an equal number of shares, each subject to the terms and conditions set forth in the Purchase Agreement.
ALSO-
Per tailwinds from a 10/7 email:
"Hi Ed,
Basically Terren bridged the company some money until they get their IPO done. Hopefully that’s soon. I return to the US tomorrow evening and will be back in the office on Wednesday. Will provide an update to readers when I get some information.
Regards,
Daniel Carlson Managing Partner daniel@tailwindsresearch.com +1 415 509 4590
News 
Market Data 
Discover 
